Green day on Friday for Catalyst Pharmaceuticals
(Updated on Sep 30, 2022)

Sell candidate since 2022-09-19 Loss -1.08% PDF

The Catalyst Pharmaceuticals stock price gained 1.02% on the last trading day (Friday, 30th Sep 2022), rising from $12.70 to $12.83. During the last trading day the stock fluctuated 4.84% from a day low at $12.60 to a day high of $13.21. The price has fallen in 6 of the last 10 days and is down by -4.33% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 338 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $28.04 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $12.40 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 66.04% during the next 3 months and, with a 90% probability hold a price between $20.59 and $27.88 at the end of this 3-month period.

Signals & Forecast

There are mixed signals in the stock today. The Catalyst Pharmaceuticals stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $13.75. On a fall, the stock will find some support from the short-term average at $12.41. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, September 14, 2022, and so far it has fallen -17.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss

Catalyst Pharmaceuticals finds support from accumulated volume at $12.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.61 between high and low, or 4.84%. For the last week, the stock has had daily average volatility of 3.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Catalyst Pharmaceuticals to open at $12.88, and during the day (based on 14 day Average True Range), to move between $12.09 and $13.57, which gives a possible trading interval of +/-$0.74 (+/-5.77%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 11.54% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.75 (0.62%) than the resistance at $13.62 (6.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Catalyst Pharmaceuticals stock A Buy?

Catalyst Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.414

Sell Candidate Unchanged

Remember To Visit Our YouTube Channel